DOCSLIB.ORG

This Is Not a Textual Record. This Is Used As an Administrative Marker by the William J

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
This Is Not a Textual Record. This Is Used As an Administrative Marker by the William J FOIA Number: 2013-0365-F FOIA MARKER This is not a textual record. This is used as an administrative marker by the William J. Clinton Presidential Library Staff. Collection/Record Group: Clinton Presidential Records Subgroup/Office of Origin: Records Management - SUBJECT FILE Series/Staff Member: Subject Files Subseries: OA/ID Number: 21908 Scan ID: 296995 [2] Document Number: Folder Title: FA004 Stack: Row: Section: Shelf: Position: 83 6 THE WHITE HOUSE WASHINGTON December 16, 1999 Paper Copy Generaied ic LPWJC "^^dr.. Donald A. Glaser Department of Molecular & Cell Biology University of California, Berkeley Suite 3206 229 Stanley Hall Berkeley, California 94720-3206 Dear Donald: Thank you for your letter regarding human pluripotent stem cell funding. I appreciate knowing your thoughts on this important matter and regret that I was unable to respond sooner. Last November, I asked my National Bioethics Advisory Commission to undertake a thorough review of the ethical and medical considerations associated with human stem cell research. After much thought and deliberation, we determined that human stem cell technology's potential medical benefits are compelling and worthy of pursuit as long as the research is conducted according to the highest ethical standards. As you know, stem cell research has potential application for treating people with diabetes, heart disease, Parkinson's disease, cancer, and spinal cord injury. The NIH will be putting together guidelines to ensure that the cells are obtained in an ethically sound manner. As we continue to address this complex issue, I am grateful for your input. Sincerely, THE WHITE HOUSE WASHINGTON December 16, 1999 Paper Copy Generated by LPWJC Joseph L. Goldstein Department of Molecular Genetics University of Texas Southwestern Medical Center 5323 Harry Hines Boulevard Dallas, Texas 75232-9046 Dear Joseph: Thank you for your letter regarding human pluripotent stem cell funding. I appreciate knowing your thoughts on this important matter and regret that I was unable to respond sooner. Last November, I asked my National Bioethics Advisory Commission to undertake a thorough review of the ethical and medical considerations associated with human stem cell research. After much thought and deliberation, we determined that human stem cell technology's potential medical benefits are compelling and worthy of pursuit as long as the research is conducted according to the highest ethical standards. As you know, stem cell research has potential application for treating people with diabetes, heart disease, Parkinson's disease, cancer, and spinal cord injury. The NIH will be putting together guidelines to ensure that the cells are obtained in an ethically sound manner. As we continue to address this complex issue, I am grateful for your input. Sincerely, THE WHITE HOUSE WASHINGTON December 16, 1999 Paper Copy Generated by LPWJC Roger Guillemin The Salk Institute for Biological Studies 7316 Encelia Drive La Jolla, California 92037 Dear Roger: Thank you for your letter regarding human pluripotent stem cell funding. I appreciate knowing your thoughts on this important matter and regret that I was unable to respond sooner. Last November, I asked my National Bioethics Advisory Commission to undertake a thorough review of the ethical and medical considerations associated with human stem cell research. After much thought and deliberation, we determined that human stem cell technology's potential medical benefits are compelling and worthy of pursuit as long as the research is conducted according to the highest ethical standards. As you know, stem cell research has potential application for treating people with diabetes, heart disease, Parkinson's disease, cancer, and spinal cord injury. The NIH will be putting together guidelines to ensure that the cells are obtained in an ethically sound manner. As we continue to address this complex issue, I am grateful for your input. Sincerely, THE WHITE HOUSE WASHINGTON December 16, 1999 Paper Copy Generated by LPWJC ?rbfeeeer Dudley Herschbach Department of Chemistry Harvard University 12 Oxford Street Cambridge, Massachusetts 02138 Dear Dudley: Thank you for your letter regarding human pluripotent stem cell funding. I appreciate knowing your thoughts on this important matter and regret that I was unable to respond sooner. Last November, I asked my National Bioethics Advisory Commission to undertake a thorough review of the ethical and medical considerations associated with human stem cell research. After much thought and deliberation, we determined that human stem cell technology's potential medical benefits are compelling and worthy of pursuit as long as the research is conducted according to the highest ethical standards. As you know, stem cell research has potential application for treating people with diabetes, heart disease, Parkinson's disease, cancer, and spinal cord injury. The NIH will be putting together guidelines to ensure that the cells are obtained in an ethically sound manner. As we continue to address this complex issue, I am grateful for your input. Sincerely, THE WHITE HOUSE WASHINGTON Paper Copy Generated by December 16, 1999 LPWJC <^Tirofcaoor David H. Hubel Cf^5^fes"sqr_J:l^^ Npnrnm n1 nny John Franklin Enders University Harvard Medical School 25 Shattuck Street Boston, Massachusetts 02115-6092 Dear David: Thank you for your letter regarding human pluripotent stem cell funding. I appreciate knowing your thoughts on this important matter and regret that I was unable to respond sooner. Last November, I asked my National Bioethics Advisory Commission to undertake a thorough review of the ethical and medical considerations associated with human stem cell research. After much thought and deliberation, we determined that human stem cell technology's potential medical benefits are compelling and worthy of pursuit as long as the research is conducted according to the highest ethical standards. As you know, stem cell research has potential application for treating people with diabetes, heart disease, Parkinson's disease, cancer, and spinal cord injury. The NIH will be putting together guidelines to ensure that the cells are obtained in an ethically sound manner. As we continue to address this complex issue, I am grateful for your input. Sincerely, THE WHITE HOUSE WASHINGTON December 16, 1999 Paper Copy Generated by LPWJC ^^se^^ssCT Arthur Kornberg Professor of Biochemistry Stanford University Medical Center Suite M121 300 Pasteur Drive Stanford, California 94305-5119 Dear Arthur: Thank you for your letter regarding human pluripotent stem cell funding. I appreciate knowing your thoughts on this important matter and regret that I was unable to respond sooner. Last November, I asked my National Bioethics Advisory Commission to undertake a thorough review of the ethical and medical considerations associated with human stem cell research. After much thought and deliberation, we determined that human stem cell technology's potential medical benefits are compelling and worthy of pursuit as long as the research is conducted according to the highest ethical standards. As you know, stem cell research has potential application for treating people with diabetes, heart disease, Parkinson's disease, cancer, and spinal cord injury. The NIH will be putting together guidelines to ensure that the cells are obtained in an ethically sound manner. As we continue to address this complex issue, I am grateful for your input. Sincerely, THE WHITE HOUSE WASHINGTON December 16, 1999 Paper Copy Generated by LPWJC ^^rofooDO^r Edwin G. Krebs Professor Emeritus Department of Pharmacology University of Washington Box 357280 Seattle, Washington 98195 Dear Edwin: Thank you for your letter regarding human pluripotent stem cell funding. I appreciate knowing your thoughts on this important matter and regret that I was unable to respond sooner. Last November, I asked my National Bioethics Advisory Commission to undertake a thorough review of the ethical and medical considerations associated with human stem cell research. After much thought and deliberation, we determined that human stem cell technology's potential medical benefits are compelling and worthy of pursuit as long as the research is conducted according to the highest ethical standards. As you know, stem cell research has potential application for treating people with diabetes, heart disease, Parkinson's disease, cancer, and spinal cord injury. The NIH will be putting together guidelines to ensure that the cells are obtained in an ethically sound manner. As we continue to address this complex issue, I am grateful for your input. Sincerely, THE WHITE HOUSE WASHINGTON December 16, 1999 Paper Copy Generated LPWJC Joshua Lederberg President ^^ocew^^ The Rockefeller University 123 0 York Avenue New York, New York 10021-6399 Dear Joshua: Thank you for your letter regarding human pluripotent stem cell funding. I appreciate knowing your thoughts on this important matter and regret that I was unable to respond sooner. Last November, I asked my National Bioethics Advisory Commission to undertake a thorough review of the ethical and medical considerations associated with human stem cell research. After much thought and deliberation, we determined that human stem cell technology's potential medical benefits are compelling and worthy of pursuit as long as the research is conducted according to the highest ethical standards. As you know, stem cell research has potential application for treating people with diabetes, heart disease, Parkinson's
Load more

Recommended publications
  • Caribbean Women in Science and Their Careers
    CARIBBEAN WOMEN IN SCIENCE AND THEIR CAREERS Author: NIHERST Publisher: NIHERST Editors: Christiane Francois, Joycelyn Lee Young and Trinity Belgrave Researchers/Writers: Stacey-Ann Sarjusingh, Sasha James, Keironne Banfield-Nathaniel and Alana Xavier Design/Layout: Justin Joseph and Phoenix Productions Ltd Print: Scrip J Some of the photographs and material used in this publication were obtained from the Internet, other published documents, featured scientists and their institutions. This publication is NOT FOR SALE. Copyright August 2011 by NIHERST All rights reserved. No part of this publication may be reproduced or transmitted in any form or by any means or stored in a database or retrieval system without prior written permission of NIHERST. For further information contact: NIHERST 43-45 Woodford Street, Newtown, Port-of-Spain E-mail: [email protected] Website: www.niherst.gov.tt Telephone: 868-622-7880 Fax: 868-622-1589 ISBN 978-976-95273-6-2 Funding: Ministry of Science, Technology & Tertiary Education, Trinidad and Tobago Foreword Acknowledgements List of Abbreviations Camille Wardrop Alleyne Aerospace Engineer 6 Zulaika Ali Neonatologist 48 Frances Chandler Agronomist 8 Nita Barrow Nurse 50 Hilary Ann Robotham Westmeier Analytical Chemist 10 Susan Walker Nutritionist 52 Camille Selvon Abrahams Animator 12 Anesa Ahamad Oncologist 54 Shirin Haque Astronomer 14 Celia Christie-Samuels Paediatrician 56 Dolly Nicholas Chemist 16 Kathleen Coard Pathologist 58 Patricia Carrillo Construction Manager 18 Merle Henry Pharmacist 60 Rosalie
    [Show full text]
  • Download The
    ii Science as a Superpower: MY LIFELONG FIGHT AGAINST DISEASE AND THE HEROES WHO MADE IT POSSIBLE By William A. Haseltine, PhD YOUNG READERS EDITION iii Copyright © 2021 by William A. Haseltine, PhD All rights reserved. No part of this book may be used or reproduced by any means, graphic, electronic, or mechanical, including photocopying, recording, taping, or by any information storage retrieval system, without the written permission of the publisher except in the case of brief quotations embodied in critical articles and reviews. iv “If I may offer advice to the young laboratory worker, it would be this: never neglect an extraordinary appearance or happening.” ─ Alexander Fleming v CONTENTS Introduction: Science as A Superpower! ............................1 Chapter 1: Penicillin, Polio, And Microbes ......................10 Chapter 2: Parallax Vision and Seeing the World ..........21 Chapter 3: Masters, Mars, And Lasers .............................37 Chapter 4: Activism, Genes, And Late-Night Labs ........58 Chapter 5: More Genes, Jims, And Johns .........................92 Chapter 6: Jobs, Riddles, And Making A (Big) Difference ......................................................................107 Chapter 7: Fighting Aids and Aiding the Fight ............133 Chapter 8: Down to Business ...........................................175 Chapter 9: Health for All, Far and Near.........................208 Chapter 10: The Golden Key ............................................235 Glossary of Terms ..............................................................246
    [Show full text]
  • Federation Member Society Nobel Laureates
    FEDERATION MEMBER SOCIETY NOBEL LAUREATES For achievements in Chemistry, Physiology/Medicine, and PHysics. Award Winners announced annually in October. Awards presented on December 10th, the anniversary of Nobel’s death. (-H represents Honorary member, -R represents Retired member) # YEAR AWARD NAME AND SOCIETY DOB DECEASED 1 1904 PM Ivan Petrovich Pavlov (APS-H) 09/14/1849 02/27/1936 for work on the physiology of digestion, through which knowledge on vital aspects of the subject has been transformed and enlarged. 2 1912 PM Alexis Carrel (APS/ASIP) 06/28/1873 01/05/1944 for work on vascular suture and the transplantation of blood vessels and organs 3 1919 PM Jules Bordet (AAI-H) 06/13/1870 04/06/1961 for discoveries relating to immunity 4 1920 PM August Krogh (APS-H) 11/15/1874 09/13/1949 (Schack August Steenberger Krogh) for discovery of the capillary motor regulating mechanism 5 1922 PM A. V. Hill (APS-H) 09/26/1886 06/03/1977 Sir Archibald Vivial Hill for discovery relating to the production of heat in the muscle 6 1922 PM Otto Meyerhof (ASBMB) 04/12/1884 10/07/1951 (Otto Fritz Meyerhof) for discovery of the fixed relationship between the consumption of oxygen and the metabolism of lactic acid in the muscle 7 1923 PM Frederick Grant Banting (ASPET) 11/14/1891 02/21/1941 for the discovery of insulin 8 1923 PM John J.R. Macleod (APS) 09/08/1876 03/16/1935 (John James Richard Macleod) for the discovery of insulin 9 1926 C Theodor Svedberg (ASBMB-H) 08/30/1884 02/26/1971 for work on disperse systems 10 1930 PM Karl Landsteiner (ASIP/AAI) 06/14/1868 06/26/1943 for discovery of human blood groups 11 1931 PM Otto Heinrich Warburg (ASBMB-H) 10/08/1883 08/03/1970 for discovery of the nature and mode of action of the respiratory enzyme 12 1932 PM Lord Edgar D.
    [Show full text]
  • Laureatai Pagal Atradimų Sritis
    1 Nobelio premijų laureatai pagal atradimų sritis Toliau šioje knygoje Nobelio fiziologijos ir medicinos premijos laureatai suskirstyti pagal jų atradimus tam tikrose fiziologijos ir medicinos srityse. Vienas laureatas gali būti įrašytas keliose srityse. Akies fiziologija 1911 m. Švedų oftalmologas Allvar Gullstrand – už akies lęšiuko laužiamosios gebos tyrimus. 1967 m. Suomių ir švedų neurofiziologas Ragnar Arthur Granit, amerikiečių fiziologai Haldan Keffer Hartline ir George Wald – už akyse vykstančių pirminių fiziologinių ir cheminių procesų atradimą. Antibakteriniai vaistai 1945 m. Škotų mikrobiologas seras Alexander Fleming, anglų biochemikas Ernst Boris Chain ir australų fiziologas seras Howard Walter Florey – už penicilino atradimą ir jo veiksmingumo gydant įvairias infekcijas tyrimus. 1952 m. Amerikiečių mikrobiologas Selman Abraham Waksman – už streptomicino, pirmojo efektyvaus antibiotiko nuo tuberkuliozės, sukūrimą. Audiologija 1961 m. Vengrų biofizikas Georg von Békésy – už sraigės fizinio dirginimo mechanizmo atradimą. Bakteriologija 1901 m. Vokiečių fiziologas Emil Adolf von Behring – už serumų terapijos darbus, ypač pritaikius juos difterijai gydyti (difterijos antitoksino sukūrimą). 1905 m. Vokiečių bakteriologas Heinrich Hermann Robert Koch – už tuberkuliozės tyrimus ir atradimus. 1928 m. Prancūzų bakteriologas Charles Jules Henri Nicolle – už šiltinės tyrimus. 1939 m. Vokiečių bakteriologas Gerhard Johannes Paul Domagk – už prontozilio antibakterinio veikimo atradimą. 1945 m. Škotų mikrobiologas Alexander Fleming, anglų biochemikas Ernst Boris Chain ir australų fiziologas Howard Walter Florey – už penicilino atradimą ir jo veiksmingumo gydant įvairias infekcijas tyrimus. 1952 m. Amerikiečių mikrobiologas Selman Abraham Waksman – už streptomicino, pirmojo efektyvaus antibiotiko nuo tuberkuliozės, sukūrimą. 2005 m. 2 Australų mikrobiologas Barry James Marshall ir australų patologas John Robin Warren – už bakterijos Helicobacter pylori atradimą ir jos įtakos skrandžio ir dvylikapirštės žarnos opos atsivėrimui nustatymą.
    [Show full text]
  • Curriculum Vitae Prof. Dr. John Franklin Enders
    Curriculum Vitae Prof. Dr. John Franklin Enders Name: John Franklin Enders Lebensdaten: 10. Februar 1897 ‐ 8. September 1985 John F. Enders war ein amerikanischer Virologe und Bakteriologe. Er war maßgeblich an der Erfor‐ schung und Entwicklung moderner Impfstoffe beteiligt. Gemeinsam mit Frederick Chapman Robbins und Thomas Huckle Weller entdeckte er die Fähigkeit des Poliovirus, in Kulturen verschiedener Ge‐ webstypen zu wachsen. Damit wurde es erstmals möglich, einen wirksamen Impfstoff gegen Kinder‐ lähmung herzustellen. Für diese Leistung wurden Enders und seine beiden Kollegen 1954 mit dem Nobelpreis für Physiologie oder Medizin ausgezeichnet. Werdegang John Enders‘ Ausbildungsweg war lang und kurvenreich: Er begann 1915 ein Studium an der Yale University, das er wegen des Ersten Weltkriegs unterbrechen musste, um als Pilot in der US‐ Luftwaffe zu dienen. 1920 schloss er sein Studium mit dem akademischen Grad eines Bachelors ab. Im Anschluss arbeitete er als Grundstücksmakler. Eine Tätigkeit, die ihn ebenso wenig befriedigte wie ein später angeschlossenes Literatur‐ und Sprachenstudium, mit dem er eigentlich eine Laufbahn als Englischlehrer angestrebt hatte. Schließlich nahm er in Yale ein Studium der Bakteriologie und Im‐ munologie auf, das er 1930 mit der Dissertation abschloss. Im Anschluss war er bis 1946 an der Yale University tätig. Neben seinen Forschungen an Mykobakterien widmete er sich der Erforschung der Pneumokokken. Seine erste Arbeit auf dem Gebiet der Virologie erschien 1939. Danach befasste er sich fast aus‐ schließlich mit Viren und untersuchte unter anderem den Wert der Gewebekulturtechnik für die Virenvermehrung. Ein wesentlicher Erfolg gelang ihm auf dem Gebiet der serologischen Technik zum Nachweis von Antikörpern des Mumpsvirus. Dazu verwendete er erstmalig ein Anti‐Gen aus infizier‐ tem Parotisgewebe von infizierten Affen.
    [Show full text]
  • Why So Few Nobel Prizes for Cancer Researchers?
    The University of Manchester Research Why so few Nobel Prizes for cancer researchers? DOI: https://doi.org/10.1007/s00432-021-03671-x Document Version Final published version Link to publication record in Manchester Research Explorer Citation for published version (APA): Hansson, N., Padrini, G., Moll, F. H., Halling, T., & Timmermann, C. (2021). Why so few Nobel Prizes for cancer researchers? An analysis of Nobel Prize nominations for German physicians with a focus on Ernst von Leyden and Karl Heinrich Bauer. Journal of Cancer Research and Clinical Oncology. https://doi.org/10.1007/s00432-021- 03671-x Published in: Journal of Cancer Research and Clinical Oncology Citing this paper Please note that where the full-text provided on Manchester Research Explorer is the Author Accepted Manuscript or Proof version this may differ from the final Published version. If citing, it is advised that you check and use the publisher's definitive version. General rights Copyright and moral rights for the publications made accessible in the Research Explorer are retained by the authors and/or other copyright owners and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights. Takedown policy If you believe that this document breaches copyright please refer to the University of Manchester’s Takedown Procedures [http://man.ac.uk/04Y6Bo] or contact [email protected] providing relevant details, so we can investigate your claim. Download date:23. Sep. 2021 Journal of Cancer Research and Clinical Oncology https://doi.org/10.1007/s00432-021-03671-x ORIGINAL ARTICLE – CANCER RESEARCH Why so few Nobel Prizes for cancer researchers? An analysis of Nobel Prize nominations for German physicians with a focus on Ernst von Leyden and Karl Heinrich Bauer Nils Hansson1 · Giacomo Padrini1 · Friedrich H.
    [Show full text]
  • Printwhatyoulike on ノーベル生理学・医学賞
    ノーベル生理学・医学賞 出典: フリー百科事典『ウィキペディア（Wikipedia）』 ノーベル賞 > ノーベル生理学・医学賞 ノーベル生理学・医学賞（ノーベルせいりがく・いがくしょう）はノーベル賞6部門のうちの1つ。「（動物）生理学及び医学の分野で 最も重要な発見を行なった」人に与えられる。選考はカロリンスカ研究所のノーベル賞委員会が行う。 歴代受賞者 [編集] 年度 受賞者名 国籍 受賞理由 エミール・アドルフ・フォン・ 血清療法の研究、特にジフテリアに対するものによって、 1901 ベーリング ドイツ帝国 医学の新しい分野を切り開き、生理学者の手に疾病や死 年 Emil Adolf von Behring に勝利しうる手段を提供したこと 1902 ロナルド・ロス マラリアの研究によってその感染経路を示し、疾病やそれ イギリス 年 Ronald Ross に対抗する手段に関する研究の基礎を築いたこと 1903 ニールス・フィンセン 疾病の治療法への寄与、特に尋常性狼瘡への光線治療法 デンマーク 年 Niels Ryberg Finsen によって、医学の新しい領域を開拓したこと 1904 イワン・パブロフ 消化生理の研究により、その性質に関する知見を転換し ロシア連邦 年 Ivan Petrovich Pavlov 拡張したこと 1905 ロベルト・コッホ ドイツ帝国 結核に関する研究と発見 年 Robert Koch カミッロ・ゴルジ イタリア王国 Camillo Golgi 1906 神経系の構造研究 年 サンティアゴ・ラモン・イ・カ ハール スペイン Santiago Ramon y Cajal シャルル・ルイ・アルフォンス・ 1907 ラヴラン フランス 疾病発生における原虫類の役割に関する研究 年 Charles Louis Alphonse Laveran パウル・エールリヒ ドイツ帝国 1908 Paul Ehrlich 免疫の研究 年 イリヤ・メチニコフ ロシア連邦 Ilya Ilyich Mechnikov 1909 エーミール・コッハー スイス 甲状腺の生理学、病理学および外科学的研究 年 Emil Theodor Kocher 1910 アルブレヒト・コッセル 核酸物質を含む、タンパク質に関する研究による細胞化学 ドイツ帝国 年 Albrecht Kossel の知見への寄与 1911 アルヴァル・グルストランド スウェーデン 眼の屈折機能に関する研究 年 Allvar Gullstrand 1912 アレクシス・カレル フランス 血管縫合および臓器の移植に関する研究 年 Alexis Carrel 1913 シャルル・ロベール・リシェ フランス アナフィラキシーの研究 年 Charles Robert Richet 1914 ローベルト・バーラーニ オーストリア＝ハンガリー 内耳系の生理学および病理学に関する研究 年 Robert Bárány 帝国 1915 受賞者なし 年 1916 受賞者なし 年 1917 受賞者なし 年 1918 受賞者なし 年 1919 ジュール・ボルデ ベルギー 免疫に関する諸発見 年 Jules Bordet アウグスト・クローグ 1920 Schack August Steenberg デンマーク 毛細血管運動に関する調整機構の発見 年 Krogh 1921 受賞者なし 年 アーチボルド・ヒル イギリス 筋肉中の熱生成に関する発見 1922 Archibald Vivian Hill 年 オットー・マイヤーホフ ドイツ 筋肉における乳酸生成と酸素消費の固定的関連の発見 Otto Fritz Meyerhof
    [Show full text]
  • 24 August 2013 Seminar Held
    PROCEEDINGS OF THE NOBEL PRIZE SEMINAR 2012 (NPS 2012) 0 Organized by School of Chemistry Editor: Dr. Nabakrushna Behera Lecturer, School of Chemistry, S.U. (E-mail: [email protected]) 24 August 2013 Seminar Held Sambalpur University Jyoti Vihar-768 019 Odisha Organizing Secretary: Dr. N. K. Behera, School of Chemistry, S.U., Jyoti Vihar, 768 019, Odisha. Dr. S. C. Jamir Governor, Odisha Raj Bhawan Bhubaneswar-751 008 August 13, 2013 EMSSSEM I am glad to know that the School of Chemistry, Sambalpur University, like previous years is organizing a Seminar on "Nobel Prize" on August 24, 2013. The Nobel Prize instituted on the lines of its mentor and founder Alfred Nobel's last will to establish a series of prizes for those who confer the “greatest benefit on mankind’ is widely regarded as the most coveted international award given in recognition to excellent work done in the fields of Physics, Chemistry, Physiology or Medicine, Literature, and Peace. The Prize since its introduction in 1901 has a very impressive list of winners and each of them has their own story of success. It is heartening that a seminar is being organized annually focusing on the Nobel Prize winning work of the Nobel laureates of that particular year. The initiative is indeed laudable as it will help teachers as well as students a lot in knowing more about the works of illustrious recipients and drawing inspiration to excel and work for the betterment of mankind. I am sure the proceeding to be brought out on the occasion will be highly enlightening.
    [Show full text]
  • JOHN FRANKLIN ENDERS February 10, 1891-September 8, 1985
    NATIONAL ACADEMY OF SCIENCES JOHN FRANKLIN E NDERS 1897—1985 A Biographical Memoir by TH O M A S H. WELLER AND F R E D E R I C K C . R Obb INS Any opinions expressed in this memoir are those of the author(s) and do not necessarily reflect the views of the National Academy of Sciences. Biographical Memoir COPYRIGHT 1991 NATIONAL ACADEMY OF SCIENCES WASHINGTON D.C. JOHN FRANKLIN ENDERS February 10, 1891-September 8, 1985 BY THOMAS H. WELLER AND FREDERICK C. ROBBINS HE INVESTIGATIVE CAREER of John Enders comprised Tthree phases. For eight years he focused on pathogenic bacteria, in particular the pneumococcus. Switching in 1939 to the study of viruses, he refined tissue culture techniques for the study of viruses in vitro and made significant discov- eries regarding mumps. This work prepared the way for the cultivation in 1949 of the polio viruses in non-nervous tissues, for which he was the corecipient of the 1954 Nobel Prize in Physiology or Medicine. Never one to rest on his laurels, End- ers turned his focus to measles. This work led to the eventual production of a measles vaccine. By 1959, however, his re- search focus had shifted once again, this time to the problem of viral host-cell resistance and viral oncogenesis—the sub- ject of the final segment of a magnificently productive inves- tigative career. EDUCATION AND EARLY CAREER John Franklin Enders was born February 10, 1897, in West Hartford, Connecticut. His father headed the Hartford National Bank, and he was the first of four children in a family whose economic means were, as he once observed, "above average." Raised in a family whose business centered on finance and trade, he had little contact with science as a 47 48 BIOGRAPHICAL MEMOIRS boy.
    [Show full text]
  • Science in the Contemporary World an Encyclopedia
    Science in the Contemporary World An Encyclopedia Eric G. Swedin Santa Barbara, California Denver, Colorado Oxford, England © 2005 by Eric G. Swedin All rights reserved. No part of this publication may be reproduced, stored in a retrieval system, or transmitted, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise, except for the inclusion of brief quotations in a review, without prior permission in writing from the publisher. Library of Congress Cataloging-in-Publication Data Swedin, Eric Gottfrid. Science in the contemporary world : an encyclopedia / Eric G. Swedin. p. cm. (ABC-CLIO’s history of science series) Includes bibliographical references and index. ISBN 1-85109-524-1 (hardback : acid-free paper)–ISBN 1-85109-529-2 (eBook) 1. Science—Encyclopedias. I.Title. II. Series: ABC-CLIO’s history of science series. Q121.S94 2005 503—dc22 2004026950 07 06 05 04 10 9 8 7 6 5 4 3 2 1 This book is available on the World Wide Web as an e-book.Visit abc-clio.com for details. ABC-CLIO, Inc. 130 Cremona Drive, P.O. Box 1911 Santa Barbara, California 93116-1911 This book is printed on acid-free paper . Manufactured in the United States of America Contents Preface and Acknowledgments, xi Introduction, xiii Topic Finder, xxiii Science in the Contemporary World: An Encyclopedia A Biology and the Life Sciences, 33 Acquired Immunodeficiency Syndrome, 1 Biotechnology, 36 Agriculture, 3 Birth Control Pill, 37 Alvarez, Luis W.(1911–1988), and Walter Black Holes, 40 Alvarez (1940–), 6 Boyer, Herbert (1936–), 41 Anthropology, 7 Broecker,Wallace S.
    [Show full text]
  • Washington University Record, September 16, 1982
    Washington University School of Medicine Digital Commons@Becker Washington University Record Washington University Publications 9-16-1982 Washington University Record, September 16, 1982 Follow this and additional works at: http://digitalcommons.wustl.edu/record Recommended Citation "Washington University Record, September 16, 1982" (1982). Washington University Record. Book 243. http://digitalcommons.wustl.edu/record/243 This Article is brought to you for free and open access by the Washington University Publications at Digital Commons@Becker. It has been accepted for inclusion in Washington University Record by an authorized administrator of Digital Commons@Becker. For more information, please contact [email protected]. WASHINGTON UNIVERSITY IN ST LOUIS Western physicists gather for workshop on matter theories Scientists from Latin America, North America and Europe will meet for two weeks at WU beginning Sept. 20 to discuss recent progress in the theoretical description of many-particle systems and superdense matter. The meeting, the Sixth Pan-American Workshop on Con- densed Matter Theories — Feenberg Me- morial Symposium, is expected to pro- mote collaboration among physicists of the western hemisphere. A highlight of the workshop will be WU's annual Eugene Feenberg Memorial Lecture, to be delivered by David Pines at 4 p.m. Sept. 22 at 201 Crow Hall. Pines, a leading figure in many-body theory, is professor of physics and elec- trical engineering at the University of Illinois-Urbana, a member of the Na- tional Academy of Sciences, and the edi- tor of Review of Modern Physics. He will The first TGIF party of the school year, Sept. 3 in Bowles Plaza, attracted a crowd of relaxed students, pizza lovers and energetic dan- speak on "Elementary Excitations in the cers.
    [Show full text]
  • 088(1)047.Pdf (377.0Kb)
    International Contributions toward the Conquest of Polio The Harvard community has made this article openly available. Please share how this access benefits you. Your story matters Citation Hedley-Whyte, John, and Debra Milamed. 2018. International Contributions toward the Conquest of Polio. Ulster Medical Journal 88 (1): 47-54. Published Version https://www.ums.ac.uk/umj088/088(1)047.pdf Citable link http://nrs.harvard.edu/urn-3:HUL.InstRepos:38030313 Terms of Use This article was downloaded from Harvard University’s DASH repository, and is made available under the terms and conditions applicable to Other Posted Material, as set forth at http:// nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of- use#LAA Ulster Med J 2019;88(1):47-54 Medical History International Contributions toward the Conquest of Polio John Hedley-Whyte, M.D., F.A.C.P., F.R.C.A., Debra R. Milamed, M.S. Accepted: 5th of October 2018 Provenance: internally peer-reviewed. Key Words: Polio, Vaccines THE GOLDEN YEARS INTRODUCTION The recruitment of noted virologist George Williamson Auchinvole Dick by Eric Ashby2,3,4, Paul Mellon’s friend and In October 1986 Paul Mellon flew his own jet to Aldergrove, beneficiary, led to vital improvements in the production and thence to Ulster-American Folk Park near Omagh. To safety of polio vaccine (Fig. 2). Dick was to be awarded by Mellon’s surprise, he was met by a delegation headed by Park Johns Hopkins University the title “Hero of Public Health”5. Director Denis MacNeice. Paul Mellon was then escorted to Eric Ashby became Lord Ashby of Brandon4.
    [Show full text]